Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

SHE:300204 Revenue

Staidson (Beijing) BioPharmaceuticals had revenue of 54.94M CNY in the quarter ending September 30, 2025, a decrease of -30.10%. This brings the company's revenue in the last twelve months to 244.37M, down -30.32% year-over-year. In the year 2024, Staidson (Beijing) BioPharmaceuticals had annual revenue of 324.82M, down -10.81%.

• Revenue (ttm): 244.37M
• Revenue Growth: -30.32%
• P/S Ratio: 74.88
• Revenue / Employee: 504.89K
• Employees: 492
• Market Cap: 18.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	324.82M	-39.36M	-10.81%
Dec 31, 2023	364.18M	-184.81M	-33.66%
Jan 1, 2023	548.99M	-35.30M	-6.04%
Dec 31, 2021	584.29M	159.08M	37.41%
Dec 31, 2020	425.21M	-236.28M	-35.72%